Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ischaemic preconditioning: a clinical perspective

A Dana1, M S Sumeray, D M Yellon

  • 1Department of Academic and Clinical Cardiology, UCL Hospitals, London.

Hospital Medicine (London, England : 1998)
|August 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop.

Basic research in cardiology·2024
Same author

The Infarct-Limiting Effect of Remote Ischemic Conditioning in Rats Is Not Affected by Aspirin.

Cardiovascular drugs and therapy·2023
Same author

Search for Subsolar-Mass Binaries in the First Half of Advanced LIGO's and Advanced Virgo's Third Observing Run.

Physical review letters·2022
Same author

Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop.

Basic research in cardiology·2022
Same author

Constraints on Cosmic Strings Using Data from the Third Advanced LIGO-Virgo Observing Run.

Physical review letters·2021
Same author

Correction: Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.

Cell death & disease·2021

Ischaemic preconditioning protects the heart muscle by slowing damage and allowing more time for reperfusion therapy. Evidence indicates the human heart can be preconditioned, suggesting potential clinical applications.

Area of Science:

  • Cardiology
  • Physiology
  • Cellular Biology

Background:

  • Ischaemic preconditioning is a natural heart-protective mechanism.
  • It can limit myocardial necrosis and extend reperfusion time.
  • Emerging evidence supports its occurrence in the human myocardium.

Purpose of the Study:

  • To review the current literature on ischaemic preconditioning.
  • To explore the potential clinical relevance of this endogenous cardioprotective mechanism.
  • To identify situations where preconditioning might be therapeutically applied.

Main Methods:

  • Literature review of existing studies on myocardial preconditioning.
  • Analysis of evidence for human myocardium preconditioning.
  • Synthesis of findings to suggest clinical applications.

Related Experiment Videos

Main Results:

  • The human myocardium exhibits characteristics of ischaemic preconditioning.
  • Preconditioning offers a window for enhanced therapeutic interventions.
  • Specific clinical scenarios are proposed for its application.

Conclusions:

  • Ischaemic preconditioning is a viable endogenous cardioprotective strategy.
  • Further research into clinical applications is warranted.
  • This mechanism holds promise for improving outcomes in cardiac events.